Several studies in animal models have shown that restoring appropriate hepcidin levels can be used to treat iron-dysregulation diseases, such as hereditary hemochromatosis and iron-refractory iron deficiency anemia [19,20]. The gene discussed is HAMP; the disease is hereditary hemochromatosis.